What 2025 could bring for psychedelic use in healthcare
Experts share what they’re looking forward to in the new year following the FDA’s rejection of a psychedelic therapy.
Deep dives into Specialty Care and its impact on healthcare. From Surgery and Orthopedics to industry-wide shifts, Healthcare Brew covers the essential developments in Direct Care.
Experts share what they’re looking forward to in the new year following the FDA’s rejection of a psychedelic therapy.
Ochsner joins six other MD Anderson partner health systems across the country.
The code creates a pathway for integrating psychedelic therapies into the healthcare system.
Patients halved daily opioid use after eight months on medical cannabis.
How doctors and hospitals can prepare for cannabis-related outcomes.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.